Skip to main content

Advertisement

SpringerLink
Log in

Omics experiments in Iran, a review in endocrine and metabolism disorders studies

  • Review article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to evaluate the status of scientific research output of omics in regards to human diseases with more attention shifted toward endocrine and metabolism disorders in Iran, in order to find scientific gaps and also to design future plans for further investigations in this field.

Methods

Extensive search was performed in the electronic databases of Scopus and PubMed, and documents published by Iranian authors up to 27 December 2020 were extracted. Articles related to human diseases were included and categorized based on their types and topics.

Results

A total of 904 publications were found. Followed by checking their titles and abstracts, 327 studies were included. The trend of publication has been increasing during the past years. Regarding this subject, the highest number of publications was in the field of malignant disorders with 82 publications followed by reproductive system diseases and infectious diseases with 33 publications in each subject. Only 12 articles were found in the field of endocrinology and metabolism. The most popular techniques used in those reports were two-dimensional electrophoresis coupled with mass spectrometry (34.4 %) followed by NMR (22.6 %), LC/MS/MS (15 %).

Conclusions

Omics studies in Iran are a relatively new approach and the number of original articles regarding endocrine disorders in humans is limited. Providing appropriate infrastructures including lab facilities with high technology instruments can improve the quality and quantity of basic and clinical researches in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The dataset supporting the conclusions of this article is available and can be accessed by contacting the Corresponding Author.

References

  1. Arjmand B, Abdollahi M, Larijani B. Precision medicine: A new revolution in healthcare system. Iran Biomed J. 2017;21(5):282–3.

    PubMed  Google Scholar 

  2. Agharezaee N, Hashemi M, Shahani M, Gilany K. Male infertility, precision medicine and systems proteomics. J Reprod Infant Psychol. 2018;19(4):185–92.

    Google Scholar 

  3. Adamski J. Key elements of metabolomics in the study of biomarkers of diabetes. Diabetologia. 2016;59(12):2497–502.

    Article  CAS  Google Scholar 

  4. Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137(2):293–300.

    Article  CAS  Google Scholar 

  5. Chashmniam S, Madani NH, Ghoochani BFNM, Safari-Alighiarloo N, Khamseh ME. The metabolome profiling of obese and non-obese individuals: Metabolically healthy obese and unhealthy non-obese paradox. Iran J Basic Med Sci. 2020;23(2):186.

    PubMed  PubMed Central  Google Scholar 

  6. Bagheri M, Djazayery A, Farzadfar F, Qi L, Yekaninejad MS, Aslibekyan S, et al. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults. Lipids Health Dis. 2019;18(1):1–9.

    Article  Google Scholar 

  7. Bagheri M, Farzadfar F, Qi L, Yekaninejad MS, Chamari M, Zeleznik OA, et al. Obesity-related metabolomic profiles and discrimination of metabolically unhealthy obesity. J Proteome Res. 2018;17(4):1452–62.

    Article  CAS  Google Scholar 

  8. Bagheri M, Djazayery A, Qi L, Yekaninejad MS, Chamari M, Naderi M, et al. Effectiveness of vitamin D therapy in improving metabolomic biomarkers in obesity phenotypes: Two randomized clinical trials. Int J Obes. 2018;42(10):1782–96.

    Article  Google Scholar 

  9. Rahimi N, Razi F, Nasli-Esfahani E, Qorbani M, Shirzad N, Larijani B. Amino acid profiling in the gestational diabetes mellitus. J Diabetes Metab Disord. 2017;16(1):13.

    Article  Google Scholar 

  10. Kazemi Khoo N, Iravani A, Arjmand M, Vahabi F, Lajevardi M, Akrami SM, et al. A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. Lasers Med Sci. 2013;28(6):1527–32.

    Article  CAS  Google Scholar 

  11. Naderi N, Zaefizadeh M. Expression of growth factors in re-epithelialization of diabetic foot ulcers after treatment with non-thermal plasma radiation. Biomed Res. 2017;28(8):3402–7.

    CAS  Google Scholar 

  12. Maleki A, Ramazani A, Foroutan M, Biglari A, Ranjzad P, Mellati AA. Comparative proteomics study of streptozotocin-induced diabetic nephropathy in rats kidneys transfected with adenovirus-mediated fibromodulin gene. Avicenna J Med Biotechnol. 2014;6(2):104–12.

    PubMed  PubMed Central  Google Scholar 

  13. Abooshahab R, Hooshmand K, Razavi SA, Gholami M, Sanoie M, Hedayati M. Plasma metabolic profiling of human thyroid nodules by gas chromatography-mass spectrometry (GC-MS)-based untargeted metabolomics. Front Cell Dev Biol. 2020;8:385.

    Article  Google Scholar 

  14. Yekta RF, Oskouie AA, Tavirani MR, Mohajeri-Tehrani MR, Soroush AR. Decreased apolipoprotein A4 and increased complement component 3 as potential markers for papillary thyroid carcinoma: A proteomic study. Int J Biol Markers. 2018;33(4):455–62.

    Article  Google Scholar 

  15. Yekta RF, Tavirani MR, Oskouie AA, Mohajeri-Tehrani MR, Soroush AR, Baghban AA. Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach. Iran J Basic Med Sci. 2018;21(11):1140–7.

    Google Scholar 

  16. Abooshahab R, Gholami M, Sanoie M, Azizi F, Hedayati M. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation. Endocrine. 2019;65(1):1–14.

    Article  CAS  Google Scholar 

  17. Khatami F, Payab M, Sarvari M, Gilany K, Larijani B, Arjmand B, et al. Oncometabolites as biomarkers in thyroid cancer: A systematic review. Cancer Manag Res. 2019;11:1829–41.

    Article  CAS  Google Scholar 

  18. Farrokhi Yekta R, Rezaie Tavirani M, Arefi Oskouie A, Mohajeri-Tehrani MR, Soroush AR. The metabolomics and lipidomics window into thyroid cancer research. Biomarkers. 2017;22(7):595–603.

    CAS  PubMed  Google Scholar 

  19. Gilany K, Minai-Tehrani A, Savadi-Shiraz E, Rezadoost H, Lakpour N. Exploring the human seminal plasma proteome: An unexplored gold mine of biomarker for male Infertility and male reproduction disorder. J Reprod Infertil. 2015;16(2):61–71.

    PubMed  PubMed Central  Google Scholar 

  20. Mehrparavar B, Minai-Tehrani A, Arjmand B, Gilany K. Metabolomics of male infertility: A new tool for diagnostic tests. J Reprod Infertil. 2019;20(2):64–9.

    PubMed  PubMed Central  Google Scholar 

  21. Gilany K, Mani-Varnosfaderani A, Minai-Tehrani A, Mirzajani F, Ghassempour A, Sadeghi MR, et al. Untargeted metabolomic profiling of seminal plasma in nonobstructive azoospermia men: A noninvasive detection of spermatogenesis. Biomed Chromatogr. 2017;31(8):e3931.

    Article  Google Scholar 

  22. Gilany K, Jafarzadeh N, Mani-Varnosfaderani A, Minai-Tehrani A, Sadeghi MR, Darbandi M, et al. Metabolic fingerprinting of seminal plasma from non-obstructive azoospermia patients: Positive versus negative sperm retrieval. J Reprod Infertil. 2018;19(2):109–14.

    PubMed  PubMed Central  Google Scholar 

  23. Hashemitabar M, Sabbagh S, Orazizadeh M, Ghadiri A, Bahmanzadeh M. A proteomic analysis on human sperm tail: Comparison between normozoospermia and asthenozoospermia. J Assist Reprod Genet. 2015;32(6):853–63.

    Article  Google Scholar 

  24. Vakilian H, Mirzaei M, Sharifi Tabar M, Pooyan P, Habibi Rezaee L, Parker L, et al. DDX3Y, a male-specific region of y chromosome gene, may modulate neuronal differentiation. J Proteome Res. 2015;14(9):3474–83.

    Article  CAS  Google Scholar 

  25. Larijani B, Goodarzi P, Payab M, Alavi-Moghadam S, Rahim F, Bana N, et al. Metabolomics and cell therapy in diabetes mellitus. Int J Mol Cell Med (IJMCM). 2019;8(2):0.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Shaghayegh Hosseinkhani & Parvin Pasalar

  2. Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Babak Arjmand

  3. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Babak Arjmand, Niloufar Najjar & Farideh Razi

  4. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Fatemeh Bandarian

  5. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Hossein Aazami & Nastaran Hadizadeh

Authors
  1. Shaghayegh Hosseinkhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Babak Arjmand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatemeh Bandarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hossein Aazami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nastaran Hadizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Niloufar Najjar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Parvin Pasalar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Farideh Razi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors participated and approved the paper prior to submission. Hossein Aazami led survey implementation. Shaghayegh Hosseinkhani and Niloufar Najjar led data collection, data analysis, and preparation of the manuscript. Nastaran Hadizadeh contributed to the preparation of the manuscript and participated in critical review. Parvin Pasalar1 and Farideh Razi played key roles in the planning, implementation, and management of the study. Babak Arjmand and Fatemeh Bandarian participated in the study design, helped to refine data-collection tools, and assisted in managing data collection.

Corresponding author

Correspondence to Farideh Razi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

The study was approved by the Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences. 

Consent to participate

Not applicable. 

Consent for publication

Not applicable. 

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hosseinkhani, S., Arjmand, B., Bandarian, F. et al. Omics experiments in Iran, a review in endocrine and metabolism disorders studies. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-021-00727-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40200-021-00727-0

Keywords

Search

Navigation